Nephrogenic systemic fibrosis versus contrast-induced nephropathy: Risks and benefits of contrast-enhanced MR and CT in renally impaired patients

Diego R. Martin, Richard C. Semelka, Arlene Chapman, Harm Peters, Paul J. Finn, Bobby Kalb, Henrik Thomsen

Research output: Contribution to journalArticle

39 Scopus citations

Abstract

Magnetic resonance imaging (MRI) and computed tomography (CT) have become essential to diagnostic evaluation of many, or most, important medically and surgically treated diseases. It is important to consider comprehensively the implications in making decisions when choosing one or the other cross-sectional imaging modality. Factors to consider include the relative risks of the contrast agent. Other factors include the relative procedural risks, including radiation risks and the relative expected diagnostic yield of the examination technique (1,2). In this review we describe both nephrogenic systemic fibrosis and contrast-induced nephropathy to compare the implications with regard to relative risks and benefits of contrast-enhanced MRI or CT in patients with impaired renal function.

Original languageEnglish (US)
Pages (from-to)1350-1356
Number of pages7
JournalJournal of Magnetic Resonance Imaging
Volume30
Issue number6
DOIs
StatePublished - Dec 1 2009
Externally publishedYes

Keywords

  • Contrast agents
  • Contrast induced nephropathy
  • Contrast reactions
  • Gadolinium
  • Iodinated contrast
  • Nephrogenic systemic fibrosis

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Nephrogenic systemic fibrosis versus contrast-induced nephropathy: Risks and benefits of contrast-enhanced MR and CT in renally impaired patients'. Together they form a unique fingerprint.

  • Cite this